UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors in New Zealand, the Cayman Island, Singapore, the United States, and internationally. The company has developed a brokerage platform, Tiger Trade which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It also provides value-added services, including investor education, community engagement, and IR/PR platform services. In addition, the company offers trade execution, margin financing, and securities lending services; asset management and wealth management; ESOP management; fund license application, product design, asset custody, transaction execution, and funding allocation; fund structuring and management; and IPO underwriting services. Further, the company provides market information and simulated trading services; and trade futures contracts. UP Fintech Holding Limited was founded in 2014 and is headquartered in Singapore.…
UP Fintech Holding Limited to Report Third Quarter 2026 Financial Results on November 24, 2026
Tiger Brokers Singapore Brings Extended-Hours US Options Trading to Singapore Investors
UP Fintech Holding (NASDAQ: TIGR) is listed on Nasdaq, where its shares trade in USD. It belongs to the Capital Markets industry, part of the Financial Services sector, and reports about 1,346 employees.
The shares were at 3.670 USD on 20 November 2026, down 65.1% over 52 weeks. Its 52-week range is 3.535 USD to 11.35 USD: the price is 67.7% below the high and 3.8% above the low.
At a market capitalisation of 660.03M USD, it trades at 6.8 times trailing earnings and 4.3 times forward earnings. The median trailing P/E of its 20 largest Capital Markets peers is 15.0, a discount of 55% for TIGR.
UP Fintech Holding reports return on equity of 19.7%, an operating margin of 36.5% and revenue up 32.4% year over year.
It holds more cash than debt, a net cash position of 4.64B USD. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 11 analysts cover the stock; their mean price target of 7.165 USD is 95.2% above the current price. The next earnings report is expected on 24 November 2026.